The Weissman lab studies the identification, isolation, and function of normal and cancer stem cells, including the lineage of their precursors and progeny, and the phylogeny of stem cells in colonial protochordates.

The goal of Dr. Wang's research is to understand the regulatory mechanisms controlling mitochondrial dynamics and function and the mechanisms by which even subtle perturbations of these processes may contribute to neurodegenerative disorders.

Dr. Chen's area of research is in molecular abnormalities in connective tissue metabolism in women affected with pelvic floor disorders and stem cell treatment for female urinary incontinence.

Dr. Chaudhuri's group is interested in elucidating the underlying molecular mechanisms that give rise to the complex mechanical properties of cells, extracellular matrices, and tissues.

Dr. Chang is leading SNIP's research efforts, which can be divided into the categories of neural stem cells, new blood vessel growth and response to radiosurgery, and nanotechnology and microfluidic biochips.

Dr. Chang's clinical research revolves around understanding the association between myopia and glaucoma.

Dr. Chang's primary research interests are in the areas of multi-functional materials and intelligent structures with particular emphases on structural health monitoring, intelligent self-sensing diagnostics, and integrated health management for space and aircraft structures as well safety-critical assets and medical devices.

Dr. Chang specializes in the treatment of gastrointestinal malignancies.

Dr. Chamberlain utilizes stable and radiogenic isotopes to understand Earth system history.

Dr. Cegelski's research program integrates chemistry, biology, and physics to investigate the assembly and function of macromolecular and whole-cell systems.